Oncolytic Viruses

  • Christine E. Engeland

Part of the Methods in Molecular Biology book series (MIMB, volume 2058)

Table of contents

  1. Front Matter
    Pages i-xi
  2. Christine E. Engeland, John C. Bell
    Pages 1-6
  3. Claudia A. P. Hill, Luca Bau, Robert Carlisle
    Pages 7-29
  4. Michael D. Mühlebach, Roberto Cattaneo
    Pages 51-75
  5. Nancy Y. Villa, Lina S. Franco, Grant McFadden
    Pages 95-110
  6. Laura Dietz, Christine E. Engeland
    Pages 111-126
  7. Tiphaine Delaunay, Carole Achard, Marc Grégoire, Frédéric Tangy, Nicolas Boisgerault, Jean-François Fonteneau
    Pages 127-132
  8. Krishna Das, Carles Urbiola, Bart Spiesschaert, Philipp Mueller, Guido Wollmann
    Pages 155-177
  9. Jonathan G. Pol, Byram W. Bridle, Brian D. Lichty
    Pages 191-211
  10. Elizabeth J. Ilett
    Pages 229-236
  11. Liesa-Marie Schreiber, Carles Urbiola, Patrik Erlmann, Guido Wollmann
    Pages 237-248
  12. Eleanor M. Scott, Sally Frost, Hena Khalique, Joshua D. Freedman, Len W. Seymour, Janet Lei-Rossmann
    Pages 261-270
  13. Brian A. Keller, Marie-Ève Wedge, Abera Surendran, Carolina S. Ilkow
    Pages 271-284
  14. Irina Kiprianova, Alexandra Just, Barbara Leuchs, Jean Rommelaere, Assia L. Angelova
    Pages 295-306
  15. Johannes P. W. Heidbuechel, Daniel Abate-Daga, Christine E. Engeland, Heiko Enderling
    Pages 307-320
  16. Back Matter
    Pages 321-329

About this book


This book aims to provide a guide for virologists, translational researchers, and clinicians in the field of cancer research by providing reference protocols and methodologies from vector development through clinical translation.   Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.

 Authoritative and cutting-edge, Oncolytic Viruses: Methods and Protocols aims to ensure successful results in the further study of this vital field.


Virotherapy Vector Design immunomonitoring mathematical Modeling Talimogene laherparepvec clinical translation

Editors and affiliations

  • Christine E. Engeland
    • 1
  1. 1.Research Group Mechanisms of Oncolytic Immunotherapy, Clinical Cooperation Unit Virotherapy, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)University Hospital HeidelbergHeidelbergGermany

Bibliographic information

  • DOI
  • Copyright Information Springer Science+Business Media, LLC, part of Springer Nature 2020
  • Publisher Name Humana, New York, NY
  • eBook Packages Springer Protocols
  • Print ISBN 978-1-4939-9793-0
  • Online ISBN 978-1-4939-9794-7
  • Series Print ISSN 1064-3745
  • Series Online ISSN 1940-6029
  • Buy this book on publisher's site